Abbonarsi

Retrospective, propensity score--matched study examining the relationship between frailty and Clostridioides difficile infection in a national cohort of US veterans - 13/11/24

Doi : 10.1016/j.ajic.2024.08.020 
Kelly R. Reveles, PharmD, PhD a, b, c, , Kelsey A. Strey, PharmD a, b, Esther L. Albuquerque a, b, Damaris Jacota a, b, Xavier Jones, BS a, c, Joseph J. Carreno, PharmD, MPH d
a College of Pharmacy, The University of Texas at Austin, Austin, TX 
b School of Medicine, University of Texas Health San Antonio, San Antonio, TX 
c Research Department, South Texas Veterans Health Care System, San Antonio, TX 
d Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY 

Address correspondence to Kelly R. Reveles, PharmD, PhD, Pharmacotherapy Education and Research Center, UT Health San Antonio, 7703 Floyd Curl Drive, MC 6200, San Antonio, TX.Pharmacotherapy Education and Research Center, UT Health San Antonio7703 Floyd Curl Drive, MC 6200San AntonioTX

Riassunto

Background

Frailty is often more predictive of disease and mortality compared with chronological age. This study determined the impact of frailty on Clostridioides difficile infection (CDI) risk and outcomes in a national veteran population.

Methods

This was a retrospective cohort study of CDI and control veteran inpatients and outpatients from fiscal year 2003 to 2018. Baseline frailty was presented as the Veterans Affairs (VA) Frailty Index. Propensity score--matched analyses were conducted to compare CDI risk, CDI health outcomes, and 1-year new-onset frailty-associated conditions.

Results

A total of 11,451 CDI and 11,451 matched control patients were included. Baseline frailty conditions were more common among CDI patients, especially involuntary weight loss (6.0% vs 3.4%, P < .001) and anemia (24.6% vs 18.7%, P < .001). VA Frailty Index was significantly higher for CDI patients (0.13 vs 0.11, P = .019). Frail CDI patients were more likely to experience 30-day mortality (11.3% vs 1.1%, P < .001) and 60-day CDI recurrence (20.4% vs 16.3%, P < .001) compared with non-/prefrail CDI patients. At 1year, CDI patients were significantly more likely to be categorized as frail (19.6% vs 17.0%, P < .001).

Conclusions

This study demonstrated the potential association between frailty and CDI risk and health outcomes, as well as new-onset frailty diagnoses in patients who develop CDI.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

Clostridioides difficile infection (CDI) and frailty was studied in US veterans.
Frailty conditions were more common among CDI patients compared with non-CDI patients.
Frail CDI patients were more likely to experience mortality and CDI recurrence.
At 1year, CDI patients were more likely to be frail compared with non-CDI patients.

Il testo completo di questo articolo è disponibile in PDF.

Key Words : Mortality, Epidemiology


Mappa


 Conflicts of interest: None to report.
 Funding/support: Institutional funding from The University of Texas at Austin was used to support this work. Additionally, KRR is supported by the National Institutes of Health (UM1TR004538, P30AG044271).


© 2024  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 52 - N° 12

P. 1412-1418 - dicembre 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Post-occupancy evaluation on temporary negative pressure isolation wards with portable high-efficiency particulate air filter units used during the COVID-19 pandemic in South Korea
  • Se Jin Lee, Won Seok Lee, Joo Yeon Roh, Shin Hye Lee, Eun Seok Kim, Myoung Souk Yeo
| Articolo seguente Articolo seguente
  • “Don’t touch your face”---Effectiveness of a health communication intervention on reducing face-touching behaviors
  • Weijia Shi, Michael Mackert, Deena Kemp, Andy J. King, Yan Liu, Mike Henson-García, Jiahua Yang, Lindsay M. Bouchacourt, Alison G. Cahill

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.